|
|
Volumn 4, Issue 10, 2004, Pages 597-
|
|
Trial of antiretroviral for HIV prevention on hold.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DRUG DERIVATIVE;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
TENOFOVIR;
ARTICLE;
CAMBODIA;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
ETHICS;
FEMALE;
HEALTH CARE ORGANIZATION;
HEALTH INSURANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTERNATIONAL COOPERATION;
METHODOLOGY;
PROFESSIONAL STANDARD;
PROSTITUTION;
RESEARCH ETHICS;
STANDARD;
UNITED STATES;
ADENINE;
ANTI-HIV AGENTS;
CAMBODIA;
CONTROLLED CLINICAL TRIALS;
DOUBLE-BLIND METHOD;
ETHICS COMMITTEES, RESEARCH;
ETHICS, RESEARCH;
FEMALE;
HIV INFECTIONS;
HUMANS;
INSURANCE, HEALTH;
INTERNATIONAL COOPERATION;
NATIONAL INSTITUTES OF HEALTH (U.S.);
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
PROSTITUTION;
RESEARCH DESIGN;
UNITED STATES;
WOMEN, WORKING;
|
|
EID: 4844227209
PISSN: 14733099
EISSN: None
Source Type: Journal
DOI: 10.1016/S1473-3099(04)01159-4 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
